Shinaberger J H, Blumenkrantz M J
Postgrad Med. 1978 Nov;64(5):169-79. doi: 10.1080/00325481.1978.11714979.
In the United States, 10,000 to 18,000 new patients require therapy for end-stage renal disease each year. A combination of medical and psychosocial criteria can be used to predict whether renal transplantation or maintenance hemodialysis or peritoneal dialysis may be the most efficacious treatment. In most cases, dialysis therapy should be initiated when signs and symptoms of uremia are only subtle, usually when creatinine clearance is between 3 and 6 ml/min. One mode of therapy can be exchanged for another to suit changing needs, and vascular access should be created even in patients who ultimately will undergo peritoneal dialysis or receive a transplant.
在美国,每年有10000至18000名新患者需要接受终末期肾病治疗。医学标准和社会心理标准相结合可用于预测肾移植、维持性血液透析或腹膜透析哪种可能是最有效的治疗方法。在大多数情况下,当尿毒症的体征和症状尚不明显时,通常是肌酐清除率在3至6毫升/分钟之间时,就应开始透析治疗。一种治疗方式可根据不断变化的需求换成另一种,即使是最终要接受腹膜透析或接受移植的患者,也应建立血管通路。